Another monoclonal antibody slows diabetes in mouse study
Researchers at Johns Hopkins School of Medicine tested a monoclonal antibody drug that may prevent and reverse type I diabetes in a study on mice. The monoclonal antibody, called mAB43,…
Researchers at Johns Hopkins School of Medicine tested a monoclonal antibody drug that may prevent and reverse type I diabetes in a study on mice. The monoclonal antibody, called mAB43,…
At a special press event on April 26th, science magazine, two scientists specializing in GLP-1 receptor agonists answered journalists' questions via video conference. Most of the questions were about diabetes…